Member Info for Forensic505

So I dont risk boring you please refer to earlier posts on this thread. Dont be lazy. Do the research.

LIT has same PER as BUR as that is the correct business model comparable.

Likening MANO to LIT, is like saying Tesco should be valued on same metrics as BP because it has some petrol outlets. You need to research deeper into the core operating models of all three. Best of luck.

This is incorrect. LIT's business model is most closely aligned to Burford: the pure funding of third parties' litigation on a global basis. Nick Rowle Davies (CEO of LIT) was previously MD of Burford outside the USA. The models are identical.

In contrast, Mano is a specialist buyer (and only very rarely funder) of UK insolvency cases only. As they are able to BUY their claims, that gives them full CONTROL. They are the claimant. For this reason their metrics are far superior and therefore the company is rated very differently to LIT and BUR, who have no control. Mano cases take months to complete, BUR and LIT cases takes many years. Please research these different models very carefully before making invalid comparions.

Just an unfortunate surname for the Parabellum CEO: Howard Shams !!! :-)

But I certainly agree - this should be a hot sector for Covid litigation fallout for a number of years. All established players should benefit.

BUR will have to write off its costs of this failed judgment and will also have to pay adverse costs to the other side. Probably a £3m+ hit.

Thank you...

I have just bought in. Right kind of business for these times and their PER is far lower than Begbies. I am sure the market will correct in due course as FRP numbers are outstanding from what i can. GLA

Compny doing a good job keeping the market updated with RNS announcements.

Wow - cracking numbers (finally we have some hard numbers !!)

It won’t just be their auditors (EY) that they have to convince, the Financial Reporting Council will be watching this one like a hawk.

I may have this wrong but didnt management say that they were delaying the audited accounts but they would be out by Easter ? If right - is there a problem with the auditors or have the LSE told no one to issue results. Confused dot com !

New report out today. Market growing and shift to funded model. MANO share of that piece up to 67%

https://www.lawgazette.co.uk/news/insolvency-litigation-market-grows-to-15bn/5103831.article#.Xo7_rR6HJRM.twitter

For some reason not shown here but poster on ADVFN linked to RNS saying Diverse Income Trust newly notified as greater than 3% shareholder. Clearly an encouraging sign.

It is great to see such a fine company being so well supported. Not just by shareholders, even more importantly by new customers. There is no doubt in my mind that the World will not only be in great need of the core COVID testing products, but longer term there will be a sustained demand for these types of products. COVID will not be the last global virus outbreak of course.

Looking very exciting

Hi - the price of their bonds has fallen very sharply and very suddenly suggesting there could (stress could) be a solvency issue. I think the bonds are now regarded as "Junk" status - that is a technical term. The share price usually follows the bonds down in these situations. But these are extreme times. Very hard to know exactly what is going on with any company at the moment.

Is this the end ?

Good news and good to see global investors backing the Litigation Funding model generally. Well done LIT.

Thanks LunaNera. Good points.

I think more likely than a USA listing, an MBO backed by their Arabic SWF makes most sense at these price levels doesnt it ?